Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Real-world Study in Metastatic Colorectal Cancer Patients With Long-term Responses to Regorafenib in the US

NCT06029010 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT06029010
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06029010 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Real-world Study in Metastatic Colorectal Cancer Patients With Long-term Responses to Regorafenib in the US
Lead sponsor
Bayer
Phase
Observational
Overall status
Completed
Start date
August 31, 2023
Completion date
January 27, 2025
Enrollment
2,326 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic colorectal cancer